Overview

Founded more than 50 years ago, the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center has long been at the forefront of research on normal and abnormal brain development. The overarching mission of the Center is to improve the lives of children with intellectual disabilities by fostering basic, translational and clinical research focused on better understanding and treating these conditions.

Learn More

Donate to IDDRC

Make a Gift to the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center

Donate Now

Research Program Highlights

29 May May

Seminar: Dr. Young-Hwan Jo

Wed May 29 2024, 12:00 PM

100B, Rose F Kennedy Center

More

"Brain-liver communication in metabolic control"

Dr. Young-Hwan Jo

Albert Einstein College of Medicine

Hosted by: Adam Kohn

Highlights

Reveling in the Work of Our Rose F. Kennedy Center Programs and Research

Rose F. Kennedy Center Day - Reveling in the Work of Our Rose F. Kennedy Center Programs and Research

On Friday, April 21, 2023, the inaugural Rose F. Kennedy Center Day offered an occasion for celebration, and hope, reflecting on the 50-plus years of the center.

Read More | View the Booklet

Reducing Ableism in Medicine and Research

Reducing Ableism in Medicine and Research

Recently, NIH designated people with disabilities as a population with health disparities.

Read More

  • When It Comes To the Rarest of Diseases, the Diagnosis Isn't the Answer—It's Just the Starting Point

    Steven Walkley, D.V.M., Ph.D., and Melissa Wasserstein, M.D., write about the science behind rare diseases and the research and clinical care that Einstein and Montefiore experts provide to families of children with uncommon genetic disorders. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology. Dr. Wasserstein is professor of pediatrics and of genetics at Einstein and chief of the division of pediatric genetic medicine at Einstein and Montefiore.

  • Oral Contraception Linked to Smaller Hypothalamus

    Michael Lipton, M.D., Ph.D., discusses his study, presented as an abstract at the Radiological Society of North America annual meeting, on the association between oral contraception use and the size of the brain’s hypothalamus. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.